Edwards Martin
SEC-identified person · CIK 1640073 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Verona Pharma plc VRNA | Director | filed 2021 - 2025 |
| Morphic Holding, Inc. MORF | Director | filed 2020 - 2024 |
| Inozyme Pharma, Inc. INZY | Director | filed 2020 - 2024 |
| Reata Pharmaceuticals INC RETA | Director | filed 2020 - 2023 |
| Kalvista Pharmaceuticals, Inc. KALV | Director | filed 2019 - 2021 |
| Colucid Pharmaceuticals, Inc. CLCD | Director | filed 2015 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.